IRIS
CATTANEO, DARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.320
SA - Sud America 2.077
NA - Nord America 1.130
EU - Europa 273
AF - Africa 115
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 6.919
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 1.635
SG - Singapore 1.499
VN - Vietnam 1.147
US - Stati Uniti d'America 989
CN - Cina 275
AR - Argentina 199
ID - Indonesia 93
EC - Ecuador 84
IT - Italia 76
BD - Bangladesh 73
MX - Messico 60
HK - Hong Kong 48
ZA - Sudafrica 46
CO - Colombia 44
RU - Federazione Russa 41
PY - Paraguay 39
IQ - Iraq 37
IN - India 33
CA - Canada 31
CL - Cile 28
UA - Ucraina 23
GB - Regno Unito 19
VE - Venezuela 19
JM - Giamaica 17
DE - Germania 15
PE - Perù 15
FR - Francia 14
MA - Marocco 14
PK - Pakistan 14
EG - Egitto 12
UZ - Uzbekistan 12
DZ - Algeria 10
PL - Polonia 10
KE - Kenya 9
SA - Arabia Saudita 9
UY - Uruguay 9
DO - Repubblica Dominicana 8
ES - Italia 8
AL - Albania 7
IE - Irlanda 7
MY - Malesia 7
PH - Filippine 7
TR - Turchia 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
JP - Giappone 6
NP - Nepal 6
SN - Senegal 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
FI - Finlandia 5
HN - Honduras 5
KZ - Kazakistan 5
SE - Svezia 5
SI - Slovenia 5
BO - Bolivia 4
GT - Guatemala 4
IL - Israele 4
JO - Giordania 4
LB - Libano 4
TT - Trinidad e Tobago 4
AT - Austria 3
BG - Bulgaria 3
CR - Costa Rica 3
KW - Kuwait 3
NL - Olanda 3
OM - Oman 3
PA - Panama 3
AU - Australia 2
BE - Belgio 2
BW - Botswana 2
BY - Bielorussia 2
CH - Svizzera 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
NG - Nigeria 2
NI - Nicaragua 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KY - Cayman, isole 1
Totale 6.910
Salva come PNG Salva come JPEG
Città #
Ho Chi Minh City 426
Ashburn 302
Singapore 293
Hanoi 236
Dallas 177
San Jose 174
São Paulo 124
Beijing 100
Rio de Janeiro 57
Da Nang 51
Hong Kong 44
Haiphong 39
Biên Hòa 37
Curitiba 33
Hải Dương 33
Assago 30
Brasília 29
Guayaquil 28
Porto Alegre 26
Thái Bình 26
Belo Horizonte 23
Los Angeles 23
New York 22
Quito 22
Ninh Bình 21
Salvador 21
Campinas 20
Johannesburg 20
Guarulhos 19
Ribeirão Preto 19
Buenos Aires 17
Can Tho 17
Fortaleza 17
Mexico City 16
Santa Clara 16
Santo André 15
Sorocaba 15
Jakarta 14
Manaus 14
Thái Nguyên 14
Bogotá 13
Bắc Giang 12
Phủ Lý 12
Resistencia 12
Baghdad 11
Cape Town 11
Goiânia 11
Santiago 11
São Gonçalo 11
Viamão 11
Wilmington 11
Asunción 10
Belém 10
Buffalo 10
Caxias do Sul 10
Ha Long 10
Lấp Vò 10
Orem 10
Tashkent 10
Cotia 9
Dhaka 9
Kingston 9
Medellín 9
Milan 9
Montreal 9
Piracicaba 9
Caracas 8
Franca 8
Hortolândia 8
Juiz de Fora 8
Mauá 8
Pelotas 8
Quảng Ngãi 8
Sumaré 8
Warsaw 8
Bandung 7
Cairo 7
Carapicuíba 7
Dublin 7
Guarujá 7
Huế 7
Lima 7
Montes Claros 7
Nairobi 7
Osasco 7
Shanghai 7
Suzano 7
São Bernardo do Campo 7
São José do Rio Preto 7
Volta Redonda 7
Aracaju 6
Barra Mansa 6
Bắc Ninh 6
Chennai 6
Colombo 6
Dakar 6
Denpasar 6
Long An 6
Macapá 6
Montevideo 6
Totale 3.136
Salva come PNG Salva come JPEG
Nome #
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma. 79
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial 64
"CATCH" Study: Correct Antibiotic Therapy in Continuous Hemofiltration in the Critically Ill in Continuous Renal Replacement Therapy: A Prospective Observational Study 43
Are non-serious adverse reactions to psychiatric drugs really non-serious ? 38
Acute kidney injury in a preterm infant homozygous for the C3435T polymorphism in the ABCB1 gene given oral morphine 37
C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation 36
ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment 36
Pharmacogenomics of immunosuppressive agents: perspective for individualized therapy 36
A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy 35
Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients 34
Antibiotic Therapy Strategies for Treating Gram- Negative Severe Infections in the Critically Ill: A Narrative Review. 34
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans 34
Neonatal Outcomes of Newborns Exposed to SSRI during Pregancy: a Pharmacokinetic and Pharmacogenetic Analysis 34
Loss of Control of HIV Viremia With OTC Weight-Loss Drugs: A Call for Caution? 33
Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients 33
Appropriateness of loading dose and TDM in patients treated with teicoplanin: a single-centre observational retrospective cohort study comparing single-daily and thrice-weekly regimens 33
Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection 33
Population Pharmacokinetics of Mycophenolic Acid A Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients 33
Application Of Quality By Design Approach To Bioanalysis: Development Of A Method For Elvitegravir Quantification In Human Plasma 33
A three-in-one, long-acting, nanosuspension reformulation of off-patent antiretrovirals for low-income and middle-income countries 32
Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report 32
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure 32
Lights and shadows of the actual European guidelines on bioanalytical method validation : the case of raltegravir 32
ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor? 32
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects 32
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans 31
Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out 31
Therapeutic Drug Monitoring of Antibiotics in the Elderly: A Narrative Review 31
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV 31
A Comparison of Tenofovir Predose Concentrations in Generic Pre-exposure Prophylaxis Formulations: A Short Communication 31
Pharmacokinetics of mycophenolate sodium and comparison with the mofetil transplant recipients formulation in stable kidney 31
Liver Injury After Dietary Supplements in Patients Living With HIV: A Call to Action 31
Dosing of dolutegravir in TB/HIV co-infected patients on rifampicin: twice is (always) better than once 30
Increased levetiracetam clearance and breakthrough seizure in a pregnant patient successfully handled by intensive therapeutic drug monitoring 30
Two-hour blood cyclosporine level does not necessarily predict drug exposure and graft function outcome in stable kidney transplant recipients 30
Therapeutic drug monitoring of sirolimus: Effect of concomitant immunosuppressive therapy and optimization of drug dosing 30
Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic 30
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy 30
Analytical performance specifications for measurement uncertainty in therapeutic monitoring of immunosuppressive drugs 29
Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients 29
Aldosterone and progression of kidney disease 29
Effect of combining ACE inhibitor and statin in severe experimental nephropathy 29
Development and validation of a chromatographic ultraviolet method for the simultaneous quantification of dolutegravir and rilpivirine in human plasma 29
Ameliorating Hypertension and Insulin Resistance in Subjects at Increased Cardiovascular Risk Effects of Acetyl-L-Carnitine Therapy 29
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience 29
Psychoactive drugs and HIV: are we sure to treat our patients adequately? 29
[Functional loss of the transplanted kidney: immunological and non-immunological factors]. FT La perdita di funzione del rene trapiantato: fattori immunologici e non-immunologici 29
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: Insights from the MYSS Trial 29
Practices of therapeutic drug monitoring in tuberculosis: an international survey. 29
Drug-Drug Interactions Between Antiretrovirals and Carbamazepine/Oxcarbazepine: A Real-Life Investigation 29
Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts 29
Optimizing Antibiotic Therapy for Intravenous Drug Users: A Narrative Review Unraveling Pharmacokinetics/Pharmacodynamics Challenges 29
Assessment of sirolimus concentrations in whole blood by high-performance liquid chromatography with ultraviolet detection 28
Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics 28
Limited Sampling Strategies for the Estimation of Sirolimus Daily Exposure in Kidney Transplant Recipients on a Calcineurin Inhibitor-Free Regimen 28
When the absence of an interaction can become clinically relevant 28
Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections 28
Delayed graft function in kidney transplantation 28
Pharmacovigilance knowledge in family paediatricians. A survey study in Italy 28
Application of Quality by Design Approach to Bioanalysis: Development of a Method for Elvitegravir Quantification in Human Plasma 28
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: Evidence from a safety study with pilot efficacy measures in adult dystrophic patients 28
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions 27
Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV-Infected Patients 27
Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience 27
Development and Validation of a Chromatographic Ultraviolet Method for the Quantification of Isavuconazole in Human Plasma Samples 27
Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients? 27
Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report 27
Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review. 27
Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients 27
Transplacental passage of ritonavir-boosted darunavir in two pregnant women 27
Comparison of the in vivo pharmacokinetics and in vitro dissolution of raltegravir in HIV patients receiving the drug by swallowing or by chewing 27
Multidrug-resistant HIV viral rebound during early syphilis: a case report 27
Perceptions and patterns of use of generic drugs among Italian family pediatricians : first round results of a web survey 27
Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies 27
Comparison of different cyclosporine immunoassays to monitor C-0 and C-2 blood levels from kidney transplant recipients: Not simply overestimation 27
Pharmacogenetics of immunosuppressants and clinical outcome 27
Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience 27
Cyclosporine formulation and Kaposi's sarcoma after renal transplantation 27
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies : evidence from a safety study with pilot efficacy measures in adult dystrophic patients 26
Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots 26
Drug-induced liver steatosis in patients with HIV infection 26
Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation 26
From pharmacokinetics to pharmacogenomics: A new approach to tailor immunosuppressive therapy 26
Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detection 26
Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring 26
Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections 26
Paliperidone LAI and Aripiprazole LAI Plasma Level Monitoring in the Prophylaxis of Bipolar Disorder Type I with Manic Predominance 26
Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation 26
Doravirine/tenofovir disoproxyl fumarate/lamivudine-induced alopecia: A case report 26
Can We Rely on AGNP Therapeutic Targets also for LAI Antipsychotics? 26
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury 26
Elvitegravir/cobicistat-associated toxic optical neuropathy in an HIV-infected patient: a call for caution? 26
Second generation antipsychotics in 'real-life' paediatric patients : adverse drug reactions and clinical outcomes of drug switch 26
Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis 26
Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose? 26
Safety and efficacy of non-standard posology of paracetamol to manage pain in pediatric patients 26
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 26
Optimizing immunosuppressive drug dosing in pediatric renal transplantation 26
Can We Rely on AGNP Therapeutic Targets Also For LAI Antipsychotics? 26
Why Product Information Should not be Set in Stone: Lessons from a Decade of Linezolid Therapeutic Drug Monitoring: An Opinion Paper 26
Totale 3.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.323
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/202213 0 0 0 2 0 0 1 1 1 1 3 4
2022/202319 5 0 3 3 1 1 0 1 1 2 2 0
2023/202414 2 2 3 0 0 0 3 1 0 0 1 2
2024/202517 1 0 0 0 0 3 0 1 2 7 0 3
2025/20267.136 311 480 1.055 2.351 529 180 791 515 387 321 185 31
Totale 7.224